Influencia del confinamiento domiciliario en pacientes con hipertensión arterial y diabetes mellitus tipo 2

  1. Melissa Muñoz Castaño
  2. Laura Basarte Gaspar
  3. Pablo Salcedo Ruiz
  4. Judit Santos Marroquín
  5. Miguel Torralba González de Suso
Aldizkaria:
Revista Iberoamericana de Enfermería Comunitaria: RIdEC

ISSN: 1988-5474

Argitalpen urtea: 2021

Alea: 14

Zenbakia: 2

Orrialdeak: 42-49

Mota: Artikulua

DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Revista Iberoamericana de Enfermería Comunitaria: RIdEC

Laburpena

Introduction: Primary Care (PC) is an essential cornerstone for the control of cardiovascular conditions such as hypertension (HTN) and Type 2 diabetes mellitus (T2D). The COVID-19 pandemic represented a change in PC organization, and healthcare consultations by telephone stood out within this change. The objective is to assess the impact of home confinement due to the COVID-19 pandemic in patients with HTN and T2D. Methodology: a retrospective cohort study conducted in two urban Primary Care centres and two rural centres in Guadalajara (Spain), collecting data during the six months before and after lockdown. The analysis included gender, age, COVID-19 experience, geographic setting, body mass index (BMI), blood pressure (BP), glycosylated hemoglobin (HBa1c), glomerular filtrate (GF), microalbuminuria, and telephone follow-up during confinement. Results: the study included 221 patients. No statistically significant changes were observed in the clinical variables studied after lockdown. A mild reduction in BMI by 0.29 kg/m2 (CI95%, p= 0,02) stood out, as well as a reduction in the HBa1c level by 0.39% (CI95% p= 0.009) in those patients with telephone monitoring by nurses. Patients who presented poor control in their BP, HBa1c, glycemia, GM, or creatinine increase, showed an improvement in their parameters after lockdown (p< 0.05) versus those better controlled. Conclusion: patients with HTN and T2D have not experienced a significant impact from a clinical point of view after the home confinement due to COVID-19. Telephone monitoring by nurses has demonstrated being an important element for the best control of HBa1c.

Erreferentzia bibliografikoak

  • Arauz-Pacheco C, Parrot MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002; 25(1):134-47. Doi: https://doi.org/10.2337/diacare.25.1.134
  • Batalla-Martínez C, Gené-Badia J, Mascot-Roca JJ. ¿Y la Atención Primaria durante la pandemia? Aten Primaria. 2020; 52(9):598-9. Doi: http://doi.org/10.1016/j.aprim.2020.10.001
  • Camarelles-Guillem F. Oportunidades y amenazas para la prevención y promoción de la salud y el PAPPS en el contexto de la pandemia COVID-19. Aten Primaria. 2020; 52(7):449-51. Doi: https://doi.org/10.1016/j.aprim.2020.07.001 [17] Tranche-Iparraguirre S, Martin-Álvarez R. La semFYC y la Medicina de Familia en tiempos del Coronavirus. Aten Primaria. 2020; 52(5)291-3. Doi: https://doi.org/10.1016/j.aprim.2020.04.002
  • Capaldo B, Annunzzi G, Creanza A, Giglio C, de Angelis R, Lupoli R, et al. Blood glucose control during lockdown for COVID-19: CGM metrics in italian adults with type 1 diabetes. Diabetes Care. 2020; 43:e88-e89. Doi: https://doi.org/10.2337/dc20-1127
  • Centro de Coordinación de Alertas y Emergencias Sanitarias, Dirección General de Salud Pública, Calidad e innovación. Manejo en atención primaria y domiciliaria del COVID-19 (Documento técnico) [internet] Madrid: Ministerio de Sanidad; [citado 3 nov 2021]. 2020. Disponible en: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Manejo_primaria.pdf
  • De Nicolás-Jiménez JM, Blázquez-Recio LM, Fabregat-Domínguez MT, Palomo-Cobos L. COVID-19 y esfuerzo asistencial en Atención Primaria. Aten Primaria 2020; 52(8):588-90. Doi: https://doi.org/10.1016/j.aprim.2020.06.002
  • Di Renzo L, Gualtieri P, Pivari F, Soldati L, Attinà A, Cinelli G, et al. Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med. 2020; 18:229. Doi: https://doi.org/10.1186/s12967-020-02399-5
  • Elbarbary NS, dos Santos TJ, de Beaufort C, Agwu JC, Calliari LE, Scaramuzza AE. COVID-19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide. Pediatr Diabetes. 2020; 21(7):1083-92. Doi: https://doi.org/10.1111/pedi.13084
  • Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14(5):917-20. Doi: https://doi.org/10.1016/j.dsx.2020.05.044
  • González E. Avances en Diabetes Tipo 2. An Real Acad Med Cir Vall. [internet] 2014 [citado 3 nov 2021]; 51:77-85. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=5361606
  • Julius S, Majahalme S, Palatini P. Antihypertensive treatment of patients with diabetes and hypertension. Am J Hypertens. 2001; 14: 310S316S. Doi: https://doi.org/10.1016/S0895-7061(01)02237-3
  • Millán-Núñez-Cortés J, de la Figuera-von Wichmann M, Rodríguez-de Miguel M, Orera-Peña ML, Labrador-Barba E, Lería-Gelabert M. Práctica clínica en el manejo de la hipertensión y la diabetes en Atención Primaria: estudio ATENCION. Semergen. 2017; 43(3):196-206. Doi: http://dx.doi.org/10.1016/j.semerg.2016.04.024
  • Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia en Cardiopatía Isquémica del Sistema Nacional de Salud [internet] Madrid: Ministerio de Sanidad; 2009. p. 61-8. [citado 3 nov 2021]. Disponible en: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/docs/cardiopatia_isquemica/Estrategia_Cardiopatia_Isquemica.pdf
  • Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia en Diabetes del Sistema Nacional de Salud [internet] Madrid: Ministerio de Sanidad; 2012. p. 43-58. Disponible en: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/excelencia/cuidadospaliativosdiabetes/DIABETES/Estrategia_en_diabetes_del_SNS_Accesible.pdf
  • Orozco-Beltrán D, Brotons-Cuixart C, Alemán-Sánchez JJ, Banegas-Banegas JR, Cebrián-Cuenca AM, Gil-Guillen VF, et al. Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020. Aten Primaria. 2020; 52(2):5-31. Doi: https://doi.org/10.1016/j.aprim.2020.08.002
  • Parving H. Controlling hypertension in diabetes. Acta Diabetol. 2002; 39:S35-S40. Doi: https://doi.org/10.1007/s005920200024
  • Saltos M. Estilos de vida y factores de riesgo asociados a DM2. Revista Ciencia UNEMI. 2012; 7:8-19. Doi: https://doi.org/10.29076/issn.2528-7737vol5iss7.2012pp8-19p
  • Williams B, Mancia G, Spiering W, Agabiti R, Azizi M, Burnier M, et al. Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial. Rev Esp Cardiol. 2019; 72(2):160.e1-e78. Doi: http://doi.org/10.1016/j.recesp.2018.12.005
  • Zanchetti A, Ruilope LM. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens. 2002; 20 (11):2099-110. Doi: https://doi.org/10.1097/00004872-200211000-00001
Datuen iturria: Dialnet